Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/1999
08/26/1999WO1999033989A3 Rantes mutants and therapeutic applications thereof
08/26/1999WO1999032606A3 Neural precursor cells, method for the production and use thereof in neural defect therapy
08/26/1999WO1999031229A3 Peptides and nucleic acids derived from eisenia foetida and the use thereof
08/26/1999WO1999029906A3 Gene family with transformation modulating activity
08/26/1999WO1999028475A9 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/26/1999WO1999028342A3 Low-voltage activated calcium channel compositions and methods
08/26/1999WO1999027094A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
08/26/1999WO1999025391A3 Biodegradable polymer scaffold
08/26/1999WO1999024571A3 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
08/26/1999WO1999021965A3 In vitro differentiation of vascular smooth muscle cells, methods and reagents related thereto
08/26/1999WO1999020774A3 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
08/26/1999WO1999020769A3 Multiply-substituted protease variants
08/26/1999WO1999006428A9 Tango-72 and tango-77 nucleic acid molecules and polypeptides
08/26/1999WO1998030696A8 Secreted proteins and polynucleotides encoding them
08/26/1999WO1998004693A3 Secreted proteins and polynucleotides encoding them
08/26/1999DE19907493A1 Recombinant nucleic acid encoding modified forms of peptides involved in neurodegenerative diseases, useful for identifying potential therapeutic agents
08/26/1999DE19835633C1 Animal or human tumor cells which express immunoglobulins
08/26/1999DE19811326C1 Preparation of medicaments for the treatment of tumor diseases and for immuno-suppression
08/26/1999DE19807265A1 New adenoviral vector useful for gene therapy
08/26/1999DE19806872A1 Production of biotin by expressing S-adenosyl-methionine synthase and second biotin synthesis gene in host cells
08/26/1999CA2687533A1 Immunological methods to modulate myostatin in vertebrate subjects
08/26/1999CA2322617A1 Compounds and methods for diagnosis of tuberculosis
08/26/1999CA2321264A1 Method for producing biotin
08/26/1999CA2321224A1 Phosphodiesterase 10
08/26/1999CA2321199A1 Compositions and methods for regulating lymphocyte activation
08/26/1999CA2321196A1 Recombinant active human zona pellucida protein 3 (hzp3)
08/26/1999CA2321180A1 Isolated and purified nucleic acids comprising a gene specifically expressed in hop glands
08/26/1999CA2321176A1 Connective tissue growth factor homologs
08/26/1999CA2321140A1 Inhibitors of complement activation
08/26/1999CA2321101A1 Modified heat shock protein-antigenic peptide complex
08/26/1999CA2321044A1 A method for the production of transgenic plants using apical shoot tips
08/26/1999CA2320808A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
08/26/1999CA2320801A1 Insecticidal toxins from photorhabdus
08/26/1999CA2320799A1 Secreted proteins and polynucleotides encoding them
08/26/1999CA2320632A1 Caf1-related protein
08/26/1999CA2319079A1 Pollen specific promoter
08/26/1999CA2318811A1 Modulation of cell proliferation, methods and reagents
08/26/1999CA2317922A1 Exo1 and exo2, exocytotic proteins
08/25/1999EP0937461A1 Use of mk family as hematopoietic factor
08/25/1999EP0937389A2 Scid mouse having a normal immun response to exogenous antigens
08/25/1999EP0937258A2 Cell stress regulated human mhc class i gene
08/25/1999EP0937251A1 Purification of antigen-specific t cells
08/25/1999EP0937155A2 Resistance against nematodes and/or aphids
08/25/1999EP0937154A2 Chimera gene with several herbicide resistant genes, plant cell and plant resistant to several herbicides
08/25/1999EP0937153A1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen
08/25/1999EP0937150A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
08/25/1999EP0937149A2 Glucuronide repressors and uses thereof
08/25/1999EP0937146A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
08/25/1999EP0937145A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
08/25/1999EP0937144A1 Human eosinophil-derived basic protein
08/25/1999EP0937143A2 Secreted proteins and polynucleotides encoding them
08/25/1999EP0937142A2 Secreted proteins and polynucleotides encoding them
08/25/1999EP0937141A1 Polynucleotides encoding secreted proteins from human dendritic cells
08/25/1999EP0937137A1 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses
08/25/1999EP0937103A2 Compounds and methods for modulating cell adhesion
08/25/1999EP0937102A1 Human monocyte chemotactic proprotein
08/25/1999EP0937098A1 Recombinational cloning using engineered recombination sites
08/25/1999EP0937095A1 Targeted cytolysis of cancer cells
08/25/1999EP0936930A1 Myocardial graft constructs
08/25/1999EP0804457A4 Modified green fluorescenct proteins
08/25/1999EP0237545B2 Production of pluripotent granulocyte colony-stimulating factor
08/25/1999CN1226930A Antisense base sequences
08/25/1999CN1226897A Isolated peptides derived from mage-2
08/25/1999CN1226831A Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine
08/24/1999US5942663 Transformed biological protein
08/24/1999US5942620 Methods for producing novel conjugates of thrombin inhibitors
08/24/1999US5942496 Methods and compositions for multiple gene transfer into bone cells
08/24/1999US5942490 Cell death regulators
08/24/1999US5942437 A culturing system to increase viability and survival of cells by adding a conditioning medium produced by sertoli cells into the culture medium 48 hours prior to cyropreservation or transplantation
08/24/1999US5942436 A culturing system for hepatocytes by sandwiching the cells between two sterilized supports layers of collagen allowing the formation of the apical and basal surfaces; treatment of liver disorders; transplants
08/24/1999US5942435 Isolating and purifying embryonic stem cells by culturing dissociated cells from swine embryos in stem cell medium absent of a feeder layer, then subculturing to obtain a culture with morphological features of embryonic stem cells
08/24/1999US5942430 Esterases
08/24/1999US5942429 DEAH-box proteins
08/24/1999US5942416 Treatment of infections from bacteria using polypeptides and polynucleotides
08/24/1999US5942412 Polynucleic acid encoding variant insulin-like growth factor I receptor beta subunit and receptor
08/24/1999US5942404 Diagnosing leukemia by incubating cells with specific antibodies and detecting surface antigens
08/24/1999US5942403 Compounds and methods for the detection of t. cruzi infection
08/24/1999US5942393 Method for the detection of the presence or absence of methylthioadenosine phosphorylase (MTASE) in a cell sample by detection of the presence or absence of MTASE encoding nucleic acid in the cell sample
08/24/1999US5942385 Method for molecular diagnosis of tumor angiogenesis and metastasis
08/24/1999US5942234 Hepatitis C virus asialoglycoproteins
08/24/1999US5942225 Comprising the stem cells and one or more bioactive factors for inducing differentiation of them into a single particular lineage, e.g. bone, muscle, tendon, ligament, connective tissue cells
08/24/1999US5942222 Administering cytokines macrophage inflammatory proteins (mip-1 and 2) capable of enhancing myelopoietic colony stimulating factor, binding to heparin, and inducing local inflammation having polymorphonuclear cell infiltration
08/24/1999CA2261249A1 Scid mouse having human immune response
08/24/1999CA2248972A1 Novel compounds
08/24/1999CA1340716C Inhibition of eucaryotic pathogens and neoplasms and stimulation of fibroblasts and lymphocytes with lytic peptides
08/24/1999CA1340714C Plant structural gene expression
08/20/1999CA2261183A1 Adenoviral transfer vector for the gene transport of a dna sequence
08/19/1999WO1999041411A2 Method for diagnosis and treatment of disorders of carbohydrate metabolism
08/19/1999WO1999041404A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
08/19/1999WO1999041402A2 Targeting of genetic vaccine vectors
08/19/1999WO1999041400A1 Methods for pseudoadenoviral vector production
08/19/1999WO1999041399A1 Methods for purified aav vector production
08/19/1999WO1999041398A1 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
08/19/1999WO1999041396A1 Use of negative regulation elements for nerve-specific expression of transgenes
08/19/1999WO1999041392A1 Nucleic acid comprising the sequence of a promoter inductible by stress and a gene sequence coding for a stilbene synthase
08/19/1999WO1999041391A1 Promoter inductible in plants, sequence incorporating same and resulting product
08/19/1999WO1999041388A2 Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides
08/19/1999WO1999041387A2 Prostate-associated serine protease
08/19/1999WO1999041384A1 Splice variants of p101 protein
08/19/1999WO1999041379A2 Members of the d52 gene family